Nakajima TE, Kadowaki S, Minashi K, Nishina T, et al. Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer. Clin Cancer Res 2020 Dec 1. pii: 1078-0432.CCR-20-3559.
PMID: 33262133